We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Two Industry Partnerships Initiated to Fuel Neuroscience Research

By LabMedica International staff writers
Posted on 16 Nov 2014
Print article
Faster, more complex neural research is now attainable by combining technology from two research companies.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd. (Nazareth, Israel) that will create a truly comprehensive set of tools for neuroscience researchers that should facilitate faster and more cost-effective research. Blackrock Microsystems will integrate specific technologies from PhenoSys and NAN Instruments to offer a fully cohesive range of electrophysiology research products.

“Our partnerships with PhenoSys and NAN instruments will fundamentally change the way neuroscientists work, so that regardless of the experiment the researcher dreams up, we can now empower them to perform it,” said Andy Gotshalk, CEO of Blackrock Microsystems. “Neuroscience research is often encumbered by mix-and-match components and complicated experiment setups. These partnerships will lessen time-consuming, expensive barriers and expedite research results so that we can achieve our ultimate objective of transferring those results into clinical practice for the millions of people facing devastating neurophysiologic challenges.”

Blackrock Microsystems’ miniaturized electrodes and amplifiers, and its data acquisition platform help researchers to perform experiments on nearly unencumbered subjects, thus yielding a clearer look into the brain's natural architecture.

PhenoSys’ technology allows researchers to construct virtual-reality mazes, where scientists can implement improvised alterations to experiments, leading to considerable cost savings of both time and money. Prior to this technology, researchers spent hours constructing physical mazes and other research environments.

“Our virtual-reality technology is already transforming neuroscience research,” said York Winter, PhD, CEO and co-founder of PhenoSys, and professor of cognitive neurobiology at Humboldt University (Berlin, Germany). “By teaming up with Blackrock Microsystems, we'll be able to help even more scientists conduct experiments that were previously thought impossible.”

NAN Instruments designs and manufactures the only electrode positioning system capable of moving individual electrodes fractions of a millimeter in a three-dimensional (3D) space. With this technology, neuroscientists can differentiate between neuron groups that were previously inseparable.

“NAN Instruments prides itself on providing flexible and reliable electrode drives,” said Nabeel Abunassar, CEO of NAN Instruments, Ltd. “Our collaboration with Blackrock Microsystems, leverages our combined strengths as leaders in the field of neuroscience research to provide integrated systems for our customers on a global scale.”

Blackrock Microsystems has become a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology has been at the center of worldwide developments in brain machine interface), implantable bionic technologies and epilepsy diagnostics.

PhenoSys is a research and development company that engineers and markets advanced technology for automated animal behavior research. The PhenoSys investigators holds extensive expertise in electrical and mechanical engineering, computer science, and behavioral biology to create experimental systems used for behavioral phenotyping, brain research, experimental psychology, and diagnostic characterization of animal models for translational medicine.

NAN Instruments designs and manufactures devices for recording electrical activity from the brain and nervous system. The unique design of the company’s electrode positioning systems provides users with effective tools that allow manipulation of each electrode individually in 3D spaces.

Related Links:

Blackrock Microsystems 
PhenoSys 
NAN Instruments


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.